Skip to main content
. Author manuscript; available in PMC: 2013 Nov 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):983–989. doi: 10.1016/j.ijrobp.2012.03.005

Table 5b.

Univariate Analysis of Dose Characteristics by Tumor Site and T Stage

Inferior Hypopharynx Dose (Gy)
≤ 50 51–60 > 60
Tumor Site Oral cavity/oropharynx 20/57 (35%) 4/10 (40%) 7/7 (100%)
Larynx/hypopharynx 7/11 (64%) 7/17 (41%) 26/52 (50%)
T Stage T1/T2 9/26 (35%) 2/7 (29%) 5/11 (45%)
T3/T4 18/42 (43%) 9/20 (45%) 28/48 (58%)